GVR Report cover U.S. Artemisinic Acid Market Size, Share & Trends Report

U.S. Artemisinic Acid Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Antimalarial Injections, Antimalarial Tablets), And Segment Forecasts

U.S. Artemisinic Acid Market Summary

The U.S. artemisinic acid market size was estimated at USD 236.6 million in 2024 and is projected to reach USD 367.7 million by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The primary factors driving the U.S. artemisinic acid market include an increase in malaria cases connected to international travel, the rising global resistance to traditional antimalarials, government-supported stockpiling initiatives, and expanded research and development in semi-synthetic production methods.

Key Market Trends & Insights

  • By product, the antimalarial tablets segment held the highest market share of 80.8% in 2024 and is expected to grow at the fastest CAGR over the forecast period.

Market Size & Forecast

  • 2024 Market Size: USD 236.6 Million
  • 2033 Projected Market Size: USD 367.7 Million
  • CAGR (2025-2033): 5.0%
Ask a question about the U.S. artemisinic acid market
Try asking
✓Every figure cited from GVR research Prefer the report? Download free sample →


The rise of Plasmodium falciparum strains resistant to traditional antimalarial drugs in Africa and Southeast Asia is prompting healthcare providers and policymakers to prioritize access to fast-acting artemisinin-based treatments. As resistance patterns evolve, U.S. institutions increase their reliance on advanced artemisinic formulations, driving imports, R&D investment, and stockpiling of effective therapies to ensure readiness against more virulent malaria forms.

U.S. Artemisinic Acid market size and growth forecast (2023-2033)Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

Furthermore, biotechnology innovations such as engineered Saccharomyces cerevisiae (yeast)-have enabled more stable and scalable production of artemisinic acid. This reduces reliance on agricultural sources such as Artemisia annua, vulnerable to climate and yield variability. As pharmaceutical companies adopt these methods, the U.S. market benefits from enhanced production reliability and cost-efficiency, supporting broader distribution and emergency preparedness.

Product Insights

Based on product, the antimalarial tablets segment accounted for the largest revenue share of 80.8% and is expected to grow at the fastest CAGR over the forecast period due to rising global travel to malaria-endemic regions. As international travel rebounds post-pandemic, more Americans are visiting malaria-prone countries, increasing the demand for preventive and curative antimalarial medications. During January–December 2023, there were 68 imported malaria cases: San Diego, California (27), Pima, Arizona (18), and El Paso, Texas (23), in comparison to 28 cases in 2022. This increases prescription rates for artemisinin-based combination therapies (ACTs) in travel clinics. Furthermore, rising awareness among travelers and improved diagnostic capabilities have expanded the U.S. artemisinic acid market’s relevance beyond domestic needs.

U.S. Artemisinic Acid Market Share

To learn more about this report, icon Download Free Sample Report

The antimalarial Injections segment is projected to grow significantly over the forecast period. With increasing global mobility and travel to sub-Saharan Africa, the U.S. reports approximately 2,000 malaria cases annually, the majority caused by P. falciparum and linked to recent travel in Africa. Hospital protocols now emphasize immediate treatment to reduce mortality, driving demand for injectable artesunate.

Key U.S. Artemisinic Acid Company Insights

Some of the key players in the U.S. artemisinic acid market include Sanofi, KPC Pharmaceuticals, Inc., Guilin Pharmaceutical Co., Ltd., and others.

  • Sanofi, a global biopharmaceutical leader operating across pharmaceuticals, vaccines, and consumer health. Sanofi’s semi-synthetic artemisinin supports antimalarial therapies, underscoring its role in healthcare innovation and global disease management.

Key U.S. Artemisinic Acid Companies:

  • Sanofi
  • KPC Pharmaceuticals, Inc.
  • Guilin Pharmaceutical Co., Ltd
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis Pharmaceuticals Corporation
  • Ipca Laboratories Inc.
  • Cipla USA Inc.
  • SHINPOONG. Co, Ltd.

U.S. Artemisinic Acid Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 249.7 million

Revenue forecast in 2033

USD 367.7 million

Growth rate

CAGR of 5.0% from 2025 to 2033

Actual data

2024

Historical period

2021 - 2023

Forecast period

2025 - 2033

Quantitative units

Revenue in USD million/billion, and CAGR from 2025 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product

Key companies profiled

Sanofi; KPC Pharmaceuticals, Inc; Guilin Pharmaceutical Co., Ltd; Calyx Chemicals and Pharmaceuticals Ltd.; Novartis Pharmaceuticals Corporation; Ipca Laboratories Inc.; Cipla USA Inc.;SHINPOONG. Co, Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

U.S. Artemisinic Acid Market Report Segmentation

This report forecasts revenue growth at U.S. artemisinic acid market and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artemisinic acid market report based on product.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

    • Antimalarial Injections

    • Antimalarial Tablets

Frequently Asked Questions About This Report

About the Author(s)

Pharmaceuticals Research Team

Healthcare · Pharmaceuticals

This report was authored by the pharmaceuticals research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the pharmaceuticals segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo